SHH · 603259.SS
WuXi AppTec Co., Ltd.
CN¥146.60+CN¥3.71 (+2.6%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 15.62% below the high.
Loading market information…
SHH · 600739.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:05 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Liaoning Cheng Da Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.17% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Liaoning Cheng Da Co., Ltd.’s forward annual dividend is CN¥0.15 per share, paid annual. The forward yield is 1.53% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Liaoning Cheng Da Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Founded in Dalian, China, in 1991, Liaoning Cheng Da Co., Ltd. operates a diverse business portfolio both domestically and across international markets. Its extensive activities span four core areas: trading, medicine and healthcare, financial investment, and energy development. The company's trading arm handles a wide array of goods, including textiles, apparel, chemicals, coal, aquatic products, timber, and steel, while also providing medical insurance. Its robust medicine and healthcare division focuses on the research, development, production, and marketing of human and veterinary vaccines. This segment also manages pharmaceutical retail, wholesale, and logistics distribution, offers medical enterprise management consulting, and sells medical equipment. Furthermore, it provides services in medical technology, computer hardware and software development, technology consulting, transfer, and general technical support. In the financial sector, Liaoning Cheng Da Co., Ltd. engages in securities and fund activities, and for energy development, it is involved in oil shale projects.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:20 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥146.60+CN¥3.71 (+2.6%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 15.62% below the high.
CN¥16.55+CN¥0.12 (+0.73%)
Shanghai Pharmaceuticals Holding Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 10.83% below the high.
CN¥5.26+CN¥0.11 (+2.14%)
Jointown Pharmaceutical Group Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 9.93% below the high.
CN¥20.26+CN¥1.84 (+9.99%)
DaShenLin Pharmaceutical Group Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 6.98% below the high.
CN¥28.04+CN¥0.26 (+0.94%)
China National Medicines Corporation Ltd.’s quoted price sits in the lower half of its reported 52-week range, 10.07% below the high.
CN¥8.91+CN¥0.04 (+0.45%)
China Meheco Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.12% below the high.
CN¥21.07+CN¥0.13 (+0.62%)
China National Accord Medicines Corporation Ltd.’s quoted price sits in the lower half of its reported 52-week range, 15.52% below the high.
CN¥10.08+CN¥0.32 (+3.28%)
Zhejiang Int'l Group Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.81% below the high.
